DURHAM, N.C.--(BUSINESS WIRE)-- Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today it has entered into an Executive Employment Agreement with Charles A. Johnson, M.D., who will become ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Inspire Pharmaceuticals has agreed to pay $6 million to ...

WHITEHOUSE STATION, N.J. & RALEIGH, N.C.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) today announced that ...

Every year, MM+M asks Agency 100 honorees what campaigns they wish they had created. Several health-related consumer campaigns popped up repeatedly in the 2024 responses, prompting the question, “How ...

Merck & Co said Tuesday it would acquire eye treatment maker Inspire Pharmaceuticals Inc for about $430 million to expand its ophthalmology business. Inspire's key product is Azasite, a treatment for ...

DURHAM, N.C. – Adrian Adams, a veteran pharmaceutical executive, is the new chief executive officer at (Nasdaq: ISPH). Adams, named to the post by the company in a statement issued early Friday, ...

Inspire Pharmaceuticals investors are now breathing easier. On Friday the drug developer released results of a late-stage study that showed that its cystic fibrosis treatment improved patients’ lung ...

Inspire names Adrian Adams as chief executive Sepracor names board member Hamanaka as chairman Feb 19 (Reuters) - Inspire Pharmaceuticals Inc appointed Adrian Adams as chief executive, effective Feb.

Inspire Pharmaceuticals, Inc. (ISPH) Q3 2008 Earnings Call October 31, 2008 10:00 AM ETExecutivesDr.

NEW YORK (MarketWatch) -- Inspire Pharmaceuticals Inc., Durham, N.C., said that based on a March 22 meeting with the U.S. Food and Drug Administration, it would give the agency more data on its ...